LAFAYETTE, La., Feb. 15, 2018 -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the fourth quarter and year ended December 31, 2017.
LHC Group plans to issue its earnings release for the fourth quarter and year ended December 31, 2017, after the market closes on Wednesday, February 28, 2018, and will host a conference call on Thursday, March 1, 2018, at 11:00 a.m. Eastern time. The toll-free number to call for this interactive teleconference is (866) 393‑1608 (international callers: (973) 890-8327). A telephonic replay of the conference call will be available through midnight on Thursday, March 8, 2018, by dialing (855) 859‑2056 (international callers: (404) 537-3406) and entering confirmation number 2883586.
A live broadcast of LHC Group’s conference call will be available under the Investor Relations section of the Company’s website, www.LHCGroup.com. A one-year online replay will be available approximately an hour following the conclusion of the live broadcast.
About LHC Group, Inc.
LHC Group, Inc. is a national provider of non-acute healthcare services, providing quality, cost‑effective healthcare to patients primarily within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of healthcare services through home health, hospice, community-based services agencies and facility-based services. LHC Group operates 320 home health services locations, 92 hospice locations, 12 community-based service locations and 15 long-term acute care hospitals (LTACHs).
Contact: Eric Elliott Senior Vice President of Finance (337) 233-1307 [email protected]


Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



